Charles River Laboratories International Inc at JPMorgan Healthcare Conference Transcript
Hi, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team. My pleasure to introduce Charles River Labs, CEO, Jim Foster, take it away.
Thanks for the introduction. So we've been working with clients from early discovery all the way through drugs getting to the clinic. And we've been innovating with our research model business, trying to accelerate time to the clinic for our clients in our Discovery and Safety Assessment business.
And we have a growing manufacturing capability which we now have a cell and gene therapy capability that we're quite excited with. A lot of stats. Last 12 months, we did a little over $4 billion in revenue. We're sort of primarily North American, is about 60%, and the balance is outside of North America. I think those percentages will be maintained given the fact that most of -- a lot of biotechers is in North America.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
